Pharma CEOs Dish on the Trump Effect

17:36 EST 1 Dec 2016 | Pharmaceutical Manfacturing

Allergan, Pfizer, Regeneron, and Merck executives express concerns and predict whether Trump will help or hurt the pharma industry

Original Article: Pharma CEOs Dish on the Trump Effect


More From BioPortfolio on "Pharma CEOs Dish on the Trump Effect"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...